GINKGO BIOWORKS HOLDINGS, INC.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Net Income | $-312.8M | $-547.0M | $-892.9M | $-2.10B | $-1.83B | $-126.6M | $-119.3M |
| Depreciation & Amortization | $59.0M | $63.0M | $70.5M | $42.6M | $29.1M | $13.9M | $10.8M |
| Depreciation | $40.3M | $45.0M | $54.8M | $36.9M | $26.9M | $12.6M | $9.6M |
| Amortization | $18.7M | $18.0M | $15.7M | $5.6M | $1.2M | $500.0K | $500.0K |
| Stock-Based Compensation | $81.5M | $112.3M | $229.9M | $1.93B | $1.61B | $476.0K | $771.0K |
| Net Cash from Operating Activities | $-171.1M | $-319.6M | $-295.5M | $-252.2M | $-253.8M | $-135.8M | $-44.7M |
| Investing Activities | |||||||
| Capital Expenditures | $7.7M | $62.5M | $40.8M | $52.3M | $56.5M | $57.8M | $22.2M |
| Business Acquisitions | $0 | $5.4M | $0 | $-82.4M | $12.0M | $0 | — |
| Net Cash from Investing Activities | $-240.3M | $-62.2M | $-80.7M | $-67.4M | $-73.3M | $-67.1M | $-74.6M |
| Financing Activities | |||||||
| Dividends Paid | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | $408.0K |
| Net Cash from Financing Activities | $17.8M | $-1.7M | $-3.2M | $95.3M | $1.53B | $90.3M | $410.4M |
| Net Change in Cash | $-393.4M | $-383.8M | $-380.0M | $-223.3M | $1.21B | $-112.6M | $291.1M |
| Free Cash Flow | $-178.7M | $-382.1M | $-336.3M | $-304.5M | $-310.3M | $-193.7M | $-66.9M |
The stock investor is neither right or wrong because others agreed or disagreed with him; he is right because his facts and analysis are right.